Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Tsai

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|October 18, 2013
MHC Class II Polymorphisms, Autoreactive T-Cells, and AutoimmunitySue Tsai, Pere Santamaria
Nature Metabolism|April 11, 2025
The art of war: burning stores to fuel anti-viral immunitySarah Q Crome, Sue Tsai
Advances in Immunology|December 30, 2008
CD8+ T cells in type 1 diabetesSue Tsai, Afshin Shameli, Pere Santamaria
Cell Metabolism|April 4, 2019
Gut T Cells Feast on GLP-1 to Modulate Cardiometabolic DiseaseSue Tsai, Shawn Winer, Daniel A Winer
Cell Metabolism|December 5, 2019
Adipose Tissue B Cells Come of Age: The AABs of Fat InflammationSaad Khan, Sue Tsai, Daniel A Winer
Cellular and Molecular Life Sciences : CMLS|June 15, 2011
CD8(+) Tregs in autoimmunity: learning "self"-control from experienceSue Tsai, Xavier Clemente-Casares, Pere Santamaria
Frontiers in Immunology|April 10, 2023
Maternal provisions in type 1 diabetes: Evidence for both protective & pathogenic potentialErin Strachan, Xavier Clemente-Casares, Sue Tsai
Immunology and Cell Biology|March 27, 2013
Quantifying the importance of pMHC valency, total pMHC dose and frequency on nanoparticle therapeutic efficacyJordan Sugarman, Sue Tsai, Pere Santamaria, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 19, 2011
Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach?Xavier Clemente-Casares, Sue Tsai, Yang Yang, et al.
Cold Spring Harbor Perspectives in Medicine|February 23, 2012
Antigen-specific therapeutic approaches in Type 1 diabetesXavier Clemente-Casares, Sue Tsai, Carol Huang, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|October 18, 2013
MHC Class II Polymorphisms, Autoreactive T-Cells, and AutoimmunitySue Tsai, Pere Santamaria
Nature Metabolism|April 11, 2025
The art of war: burning stores to fuel anti-viral immunitySarah Q Crome, Sue Tsai
Advances in Immunology|December 30, 2008
CD8+ T cells in type 1 diabetesSue Tsai, Afshin Shameli, Pere Santamaria
Cell Metabolism|April 4, 2019
Gut T Cells Feast on GLP-1 to Modulate Cardiometabolic DiseaseSue Tsai, Shawn Winer, Daniel A Winer
Cell Metabolism|December 5, 2019
Adipose Tissue B Cells Come of Age: The AABs of Fat InflammationSaad Khan, Sue Tsai, Daniel A Winer
Cellular and Molecular Life Sciences : CMLS|June 15, 2011
CD8(+) Tregs in autoimmunity: learning "self"-control from experienceSue Tsai, Xavier Clemente-Casares, Pere Santamaria
Frontiers in Immunology|April 10, 2023
Maternal provisions in type 1 diabetes: Evidence for both protective & pathogenic potentialErin Strachan, Xavier Clemente-Casares, Sue Tsai
Immunology and Cell Biology|March 27, 2013
Quantifying the importance of pMHC valency, total pMHC dose and frequency on nanoparticle therapeutic efficacyJordan Sugarman, Sue Tsai, Pere Santamaria, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 19, 2011
Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach?Xavier Clemente-Casares, Sue Tsai, Yang Yang, et al.
Cold Spring Harbor Perspectives in Medicine|February 23, 2012
Antigen-specific therapeutic approaches in Type 1 diabetesXavier Clemente-Casares, Sue Tsai, Carol Huang, et al.
Pageof 7